MAGIC: Multi-scale Heterogeneity Analysis and Clustering for Brain Diseases

• URL: http://arxiv.org/abs/2007.00812v2
• Date: Fri, 10 Jul 2020 00:50:31 GMT
• Title: MAGIC: Multi-scale Heterogeneity Analysis and Clustering for Brain Diseases
• Authors: Junhao Wen, Erdem Varol, Ganesh Chand, Aristeidis Sotiras, Christos Davatzikos
• Abstract summary: We introduce a novel method, MAGIC, to uncover disease heterogeneity by leveraging multi-scale clustering. We validate MAGIC using simulated heterogeneous neuroanatomical data and demonstrate its clinical potential by exploring the heterogeneity of Alzheimers Disease (AD) Our results indicate two main subtypes of AD with distinct atrophy patterns that consist of both fine-scale atrophy in the hippocampus as well as large-scale atrophy in cortical regions.
• Score: 3.955454029331185
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: There is a growing amount of clinical, anatomical and functional evidence for the heterogeneous presentation of neuropsychiatric and neurodegenerative diseases such as schizophrenia and Alzheimers Disease (AD). Elucidating distinct subtypes of diseases allows a better understanding of neuropathogenesis and enables the possibility of developing targeted treatment programs. Recent semi-supervised clustering techniques have provided a data-driven way to understand disease heterogeneity. However, existing methods do not take into account that subtypes of the disease might present themselves at different spatial scales across the brain. Here, we introduce a novel method, MAGIC, to uncover disease heterogeneity by leveraging multi-scale clustering. We first extract multi-scale patterns of structural covariance (PSCs) followed by a semi-supervised clustering with double cyclic block-wise optimization across different scales of PSCs. We validate MAGIC using simulated heterogeneous neuroanatomical data and demonstrate its clinical potential by exploring the heterogeneity of AD using T1 MRI scans of 228 cognitively normal (CN) and 191 patients. Our results indicate two main subtypes of AD with distinct atrophy patterns that consist of both fine-scale atrophy in the hippocampus as well as large-scale atrophy in cortical regions. The evidence for the heterogeneity is further corroborated by the clinical evaluation of two subtypes, which indicates that there is a subpopulation of AD patients that tend to be younger and decline faster in cognitive performance relative to the other subpopulation, which tends to be older and maintains a relatively steady decline in cognitive abilities.

Related papers

• Identifying latent disease factors differently expressed in patient subgroups using group factor analysis [54.67330718129736]
  We propose a novel approach to uncover subgroup-specific and subgroup-common latent factors. The proposed approach, sparse Group Factor Analysis (GFA) with regularised horseshoe priors, was implemented with probabilistic programming.
  arXiv  Detail & Related papers  (2024-10-10T13:12:14Z)
• Clustering Alzheimer's Disease Subtypes via Similarity Learning and Graph Diffusion [14.536841566365048]
  Alzheimer's disease (AD) is a complex neurodegenerative disorder that affects millions of people worldwide. In this study, we aim to identify subtypes of AD that represent distinctive clinical features and underlying pathology.
  arXiv  Detail & Related papers  (2024-10-04T21:38:14Z)
• Towards Within-Class Variation in Alzheimer's Disease Detection from Spontaneous Speech [60.08015780474457]
  Alzheimer's Disease (AD) detection has emerged as a promising research area that employs machine learning classification models. We identify within-class variation as a critical challenge in AD detection: individuals with AD exhibit a spectrum of cognitive impairments. We propose two novel methods: Soft Target Distillation (SoTD) and Instance-level Re-balancing (InRe), targeting two problems respectively.
  arXiv  Detail & Related papers  (2024-09-22T02:06:05Z)
• An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease [13.213387075528017]
  Alzheimer's disease (AD) is the most prevalent form of dementia with a progressive decline in cognitive abilities. In this study, we leveraged structural and functional MRI to investigate the disease-induced grey matter and functional network connectivity changes. We propose a novel deep learning-based classification framework where generative module employing Cycle GANs was adopted to impute missing data within the latent space.
  arXiv  Detail & Related papers  (2024-06-19T07:31:47Z)
• Patched Diffusion Models for Unsupervised Anomaly Detection in Brain MRI [55.78588835407174]
  We propose a method that reformulates the generation task of diffusion models as a patch-based estimation of healthy brain anatomy. We evaluate our approach on data of tumors and multiple sclerosis lesions and demonstrate a relative improvement of 25.1% compared to existing baselines.
  arXiv  Detail & Related papers  (2023-03-07T09:40:22Z)
• Pathology Steered Stratification Network for Subtype Identification in Alzheimer's Disease [7.594681424335177]
  Alzheimers disease (AD) is a heterogeneous, multitemporal neurodegenerative disorder characterized by beta-amyloid, pathologic tau, and neurodegeneration. We propose a novel pathology steered stratification network (PSSN) that incorporates established domain knowledge in AD pathology through a reaction-diffusion model.
  arXiv  Detail & Related papers  (2022-10-12T02:52:00Z)
• Hierarchical Graph Convolutional Network Built by Multiscale Atlases for Brain Disorder Diagnosis Using Functional Connectivity [48.75665245214903]
  We propose a novel framework to perform multiscale FCN analysis for brain disorder diagnosis. We first use a set of well-defined multiscale atlases to compute multiscale FCNs. Then, we utilize biologically meaningful brain hierarchical relationships among the regions in multiscale atlases to perform nodal pooling.
  arXiv  Detail & Related papers  (2022-09-22T04:17:57Z)
• Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease using Generative Adversarial Network [0.0]
  Frontotemporal dementia and Alzheimer's disease are two common forms of dementia and are easily misdiagnosed as each other. Differentiating between the two dementia types is crucial for determining disease-specific intervention and treatment. Recent development of Deep-learning-based approaches in the field of medical image computing are delivering some of the best performance for many binary classification tasks.
  arXiv  Detail & Related papers  (2021-09-12T22:40:50Z)
• An explainable two-dimensional single model deep learning approach for Alzheimer's disease diagnosis and brain atrophy localization [3.9281410693767036]
  We propose an end-to-end deep learning approach for automated diagnosis of Alzheimer's disease (AD) and localization of important brain regions related to the disease from sMRI data. Our approach has been evaluated on two publicly accessible datasets for two classification tasks of AD vs. cognitively normal (CN) and progressive MCI (pMCI) vs. stable MCI (sMCI) The experimental results indicate that our approach outperforms the state-of-the-art approaches, including those using multi-model and 3D CNN methods.
  arXiv  Detail & Related papers  (2021-07-28T07:19:00Z)
• G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for Biomarker Identification and Disease Classification [49.53651166356737]
  We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers. We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
  arXiv  Detail & Related papers  (2021-01-27T19:28:04Z)
• A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease Progression with MEG Brain Networks [59.15734147867412]
  Characterizing the subtle changes of functional brain networks associated with Alzheimer's disease (AD) is important for early diagnosis and prediction of disease progression. We developed a new deep learning method, termed multiple graph Gaussian embedding model (MG2G) We used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predict the progression of patients with mild cognitive impairment (MCI) to AD, and identify brain regions with network alterations related to MCI.
  arXiv  Detail & Related papers  (2020-05-08T02:29:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.